Get full access to one story every week, and to summaries of all other stories. Just create a free account

Columbia Asia Hospitals—a $2-billion chain—is up for grabs. With 29 medical facilities and 2,600 beds, that’s Columbia Asia’s total value across Asian countries like Malaysia, Vietnam, Indonesia, and of course, India. Unsurprisingly, a large number of international private equity firms (PEs) and other buyers want in.

Columbia Asia entered India in 2003 to run community hospitals. Its premise was access—people should have medical care within 10 kilometres of their homes for 70-80% of their healthcare needs. The chain’s dozen hospitals in India, however, are mid-sized, with fewer than 1,200 beds in all, and yet, the chance to buy it is being touted as a ‘once-in-a-decade’ opportunity for potential suitors.

While not confirming the outright sale of the chain, Nathan McLemore, managing director of Columbia Pacific Management, said in an email that the hospital group plans to grow by adding two new hospitals per year, with an aim for 1,100 more beds in five years. To do this, the Columbia Pacific has launched a process to raise additional capital to fund Columbia Asia’s next phase of growth. This, he says, has received strong interest from investors, adding that the capital raise is proceeding as planned. Columbia Pacific is the holding company of Columbia Asia.

Sources The Ken has spoken to, though, indicate this isn’t a simple fund raise. People close to the matter say the chain will sell all properties or nothing. “They are very open about it,” says an interested buyer from Bengaluru, who requested anonymity because his hospital group is a direct competitor. Columbia Asia, however, did not confirm the exact stake up for sale.

Columbia Asia is a desirable property because of its great locations and quality of service. In India, the chain’s hospitals occupy prime real estate in some of the most populous areas in metros. McLemore said there is substantial interest from investors as theirs is the only hospital company operating across four highly desirable markets with a single brand but that it would be premature for him to comment about valuation at this time.

But in a country rife with major private hospital chains such as Apollo, Fortis, Narayana Health, Medanta and Manipal providing specialised tertiary care, it’s hard to survive. Despite this, Columbia Asia tried to move up the value chain with secondary care.

Except, the Indian hospital business is not simple.

A. There is almost too much competition and not much to gain for a chain that doesn’t focus on super-specialty care. B. The takeover game is in full swing even amidst the big names mentioned above—Manipal Hospitals is in the process of closing its acquisition of New Delhi-based Medanta for Rs 5,800 crore ($833 million). Against this backdrop, the sale of Columbia Asia is no shocker.

That Columbia Asia is consolidating assets to make the process smoother is apparent from its corporate filings.

AUTHOR

Suraksha P

Suraksha writes on Healthcare and Pharma. She has been a journalist for five years, reporting for The New Indian Express in Bengaluru and Chennai, and The Times of India, Delhi. In her previous stints she has written on health, civic issues and education. She investigated cover up of corruption in the state health department’s think tank, narrated harrowing tales of women who underwent unwarranted hysterectomies, and wrote about how loss of biometrics came in the way of Leprosy patients getting an Aadhaar card and thereby pension. She can be reached at suraksha at the-ken dot com.

View Full Profile

Subscribe to read this story

The Ken is the only business subscription you need. Questions?

 

Premium

  • 5 original and reported longform business stories every week
  • Access to ONLY India edition
  • Close to 250 exclusive stories every year
  • Full access to over 6 years of paywalled stories
  • Pick up to 5 premium subscriber newsletters
  • 4 original and reported longform business stories each week
  • Access to ONLY Southeast Asia edition
  • Close to 200 exclusive stories every year
  • Full access to all paywalled stories since March 2020
  • Pick up to 5 premium subscriber newsletters

Rs. 2,750 /year

$ 120 /year

India Edition
Subscribe Subscribe
Most Asked For

Borderless

  • 8 original and reported longform business stories each week
  • Access to both India and Southeast Asia editions
  • Close to 400 exclusive stories every year
  • Full access to over 6 years of paywalled stories across India and Southeast Asia
  • Unlimited access to all premium subscriber newsletters
  • Visual Stories

Rs. 4,200 /year

Subscribe
 

Echelon

  • 8 original and reported longform business stories each week
  • Access to both India and Southeast Asia editions
  • Close to 400 exclusive stories every year
  • Full access to over 6 years of paywalled stories across India and Southeast Asia
  • Unlimited access to all premium subscriber newsletters
  • Visual Stories
  • Bonus annual gift subscription
  • Priority access to all new products and features

Rs. 8,474 /year

Subscribe
Or

Questions?

What kind of subscription plans do you offer?

We have three types of subscriptions
- Premium which gives you access to either the India or the Southeast Asia edition.
- Borderless which gives you complete access to The Ken across both editions
- Echelon which gives you complete access to The Ken across both editions along with a bonus gift subscription

What do I get if I subscribe?

The Premium edition gives you access to stories in that edition along with any five subscriber-only newsletters of your choice.

The Borderless and Echelon subscription gives you complete access to The Ken across editions and unlimited access to as many newsletters as you like.

What topics do you usually write about?

We publish sharp, original and reported stories on technology, business and healthcare. Our stories are forward-looking, analytical and directional — supported by data, visualisations and infographics. We use language and narrative that is accessible to even lay readers. And we optimise for quality over quantity, every single time.

Our specialised subscriber-only newsletters are written by our expert, award-winning journalists and cover a range of topics across finance, retail, clean energy, cryptocurrency, ed-tech and many more.

How many newsletters do you have?

We are constantly adding specialised subscriber-only newsletters all the time. All of these are written by our team of award-winning journalists on a specialised topic.

You can see the list of newsletters that we publish over here.

Does a Premium subscription to your Indian edition get me access to the Southeast Asia edition? Or vice-versa?

Afraid not. Each edition is separate with its own subscription plan. The India edition publishes stories focused on India. The Southeast Asia edition is focused on Southeast Asia. We may occasionally cross-publish stories from one edition to the other.

We recommend the Borderless or the Echelon Plan which will give you access to stories across both editions.

Do you have a mobile app?

Yes! We have a top-rated mobile app on both iOS and Android which allows you to read on-the-go and has some amazing features like the ability to bookmark stories, save on your device, dark mode, and much more. It’s really the best way to read The Ken.

Is there a free trial?

You can sign up for a free account to experience The Ken and understand our products better. We’ll send you some free stories and newsletters occasionally, and you can access our archive of previously published free stories. You can stay on the free account as long as you’d like.

The vast majority of our stories, articles and newsletters can be accessed only by a paid subscription.

Do you offer any discounts?

Sorry, no. Our journalism is funded completely by our subscribers. We believe that quality journalism comes at a price, and readers trust and pay us so that we can remain independent.

Do you offer refunds?

No. We allow you to sample our journalism for free before signing up, and after you do, we stand by its quality. But we do not offer refunds.

I am facing some trouble purchasing a subscription. What can I do?

Just write to us at [email protected] with details. We’ll help you out.

I have a few more questions. How can I reach out to you?

Sure. Just email us at [email protected] or follow us on Twitter.